Cargando…
First-in-Human Phase 1 Studies in Oncology: The New Challenge for Investigative Sites
Phase 1 first-in-human studies with anti-cancer products differ from other phase 1 studies in that they are evaluated in patients rather than healthy volunteers. The rationale design of targeted drugs triggers changes in the design of these studies. Patient populations are more precisely defined and...
Autor principal: | Salzberg, Marc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Rambam Health Care Campus
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678815/ https://www.ncbi.nlm.nih.gov/pubmed/23908831 http://dx.doi.org/10.5041/RMMJ.10074 |
Ejemplares similares
-
Phase 0 clinical trials in oncology new drug development
por: Gupta, Umesh Chandra, et al.
Publicado: (2011) -
Retrospective evaluation of single patient investigational new drug (IND) requests in pediatric oncology
por: Shulman, David S., et al.
Publicado: (2021) -
Phase I first-in-human study of TAK-285, a novel investigational dual HER2/EGFR inhibitor, in cancer patients
por: Doi, T, et al.
Publicado: (2012) -
A phase I first-in-man study to investigate the pharmacokinetics and safety of liposomal dexamethasone in patients with progressive multiple myeloma
por: Metselaar, Josbert, et al.
Publicado: (2023) -
New Applications of Radioguided Surgery in Oncology
por: Bitencourt, Almir Galvão Vieira, et al.
Publicado: (2009)